Contrarily, a pathogenic CHEK2 variant was detected in a patient with a GI-negative tumor, while a patient’s tumor with an inconclusive GI status harbored a likely pathogenic FANCL variant and a splice variant in ATM. The gene discussed is CHEK2; the disease is neoplasm.